In a recent study from our team [60], the transcriptomic analysis of Tregs in MS, SLE and RA patients revealed elevated expression levels of DDR-related genes as H2AFx, TP53, CHK2 and TP53BP1. Here, TP53BP1 is linked to myeloid sarcoma.